As previously mentioned, obtaining data on tumor grade and HER2 expression status remains the biggest obstacle to the implementation of the AJCC8 staging system in LMIC settings where access to pathology services tends to be limited [9,18]. The gene discussed is ERBB2; the disease is neoplasm.